PRESS / NEWS
STAY UP TO DATE WITH OUR NEWS.
Novel Approaches to Overcome CRISPR In Vitro Delivery Challenges
This article is taken from European Biopharmaceutical Review October 2020, pages 34-37. © Samedan Ltd
Check the full content of the current issue.
In order for CRISPR gene editing to reach its full potential, we must develop in vitro delivery approaches that will allow us to work with hard-to-transfect cells, large repair templates, multiplex editing projects, and minimise off-target effects.
CYTOSURGE ANNOUNCES APPOINTMENT OF THOMAS BACHMANN TO BOARD OF DIRECTORS
ZURICH | August 26, 2020
With his international management experience and extensive network in various life science markets, Thomas Bachmann is a great asset to Cytosurge and will continue to develop its strategic future markets.
OLYMPUS AND CYTOSURGE COLLABORATE TO DELIVER A COMPLETE SINGLE-CELL AND CRISPR GENETIC MANIPULATION SOLUTION IN THE AMERICAS
WALTHAM, MASS. & ZURICH | July 23, 2020
The FluidFM® BOT BIO Series combines Olympus’ renowned optics with Cytosurge’s cell manipulation expertise.
HARVARD’S WYSS INSTITUTE JOINS FORCES WITH CYTOSURGE TO IMPROVE CRISPR-BASED MULTIPLEXED GENE EDITING
BOSTON & ZURICH | May 4, 2020
Collaboration focuses on developing multiplexed gene editing approaches using single-cell nano-manipulation technology that maintains cell viability and fitness.
CYTOSURGE AG ANNOUNCES SPIN-OFF OF ITS 3D PRINTING BUSINESS UNIT
ZURICH | August 21, 2019
We are pleased to announce as of today that all 3D Printing activities of Cytosurge will be transitioned into an autonomous entity.
PARTNERSHIP BETWEEN OLYMPUS EUROPE & CYTOSURGE
ZURICH & HAMBURG | July 9, 2019
Olympus Europe and Cytosurge partner to enhance pharma drug development and single cell research.
A METAL VERSION OF MICHELANGELO'S DAVID MADE IN MICROSCALE BY ADDITIVE MANUFACTURING
ZURICH | March 21, 2019
Probably one of the most famous art sculptures in the world recreated in an entirely new perspective.
FluidFM USER CONFERENCE
ZURICH | February 7, 2019
We are proud to have recently co-organized with ETH Zurich the latest FluidFM User Conference that has considerably broadened the FluidFM community, enabled mutual exchange of knowledge and experience, which will hopefully contribute to accelerating further research.
IMPOSSIBLE OBJECTS MADE POSSIBLE
ZURICH | December 19, 2018
Can an "impossible object" be 3D printed, even impossibly small?
PREMIUM PARTNERSHIP BETWEEN
BRUKER & CYTOSURGE
ZURICH | June 29, 2018
Enabling FluidFM® single cell experiments on the BioScope Resolve® BioAFM.
FluidFM µ3Dprinter – A NEW FUNCTION ALLOWS UNIQUE PINPOINT METAL ADDITIVE MANUFACTURING
ZURICH | June 6, 2018
The FluidFM µ3Dprinter has received a major design upgrade and has been further improved with a new and unique function: Printing on existing structures with pinpoint (micrometer) accuracy.
NOVEL & UNIQUE:
FluidFM BOT FOR INJECTION
ZURICH | April 10, 2018
Conventional microinjection has its limits: these include limited cell viability, time-consuming experiments and difficulties in injecting into “small” adherent cells. The FluidFM BOT for Injection overcomes these limits.
SEARCHING FOR A FluidFM BOT DISTRIBUTION PARTNER IN GERMANY
ZURICH | April 5, 2018
Switzerland Global Enterprise, Silvana Giger
GROWING INTEREST IN CYTOSURGE'S FluidFM TECHNOLOGY
ZURICH | February 2, 2018
JPK INSTRUMENTS & CYTOSURGE
ZURICH | December 7, 2017
Making FluidFM available on the JPK Nanowizard® AFM platform.
NEW REVOLUTIONARY TOOLS FOR PHARMA AND MEDICAL RESEARCHERS READY TO GO FURTHER
November 17, 2017
GHP Magazine, November edition.
PREMIUM PARTNERSHIP BETWEEN NANOSURF & CYTOSURGE
ZURICH | October 18, 2017
Taking FluidFM solutions to the next level.
FluidFM SINGLE CELL EXTRACTION
ZURICH | July 14, 2016
Pioneering new method for the extraction of single living cells could revolutionise single cell analysis.
FluidFM MICRO 3D PRINTING
ZURICH | January 20, 2016
Groundbreaking 3D micro-printing process opens new dimensions for the fabrication of microscopic metal structures.
The company’s vision is to provide a new generation of tools to stimulate novel applications at the forefront of nanotechnology, life sciences and single cell biology in particular. We are a passionate team of specialists with backgrounds in various disciplines from business, engineering, biology and computer science.